Individual patient data meta-analysis of survival data using Poisson regression models

被引:68
作者
Crowther, Michael J. [2 ]
Riley, Richard D. [1 ]
Staessen, Jan A. [3 ,4 ]
Wang, Jiguang [5 ]
Gueyffier, Francois [6 ]
Lambert, Paul C. [2 ,7 ]
机构
[1] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Leicester, Dept Hlth Sci, Ctr Biostat & Genet Epidemiol, Leicester LE1 7RH, Leics, England
[3] Univ Leuven, Dept Cardiovasc Res, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, BE-3000 Louvain, Belgium
[4] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands
[5] Shanghai Jiao Tong Univ, Ruijin Hosp, Ctr Epidemiol Studies & Clin Trials, Shanghai 200025, Peoples R China
[6] INSERM, CIC201, F-69000 Lyon, France
[7] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden
来源
BMC MEDICAL RESEARCH METHODOLOGY | 2012年 / 12卷
关键词
PARTICIPANT DATA; META-REGRESSION; TIME; HETEROGENEITY; HAZARDS; TRIALS; FRAMEWORK; LEVEL; BIAS;
D O I
10.1186/1471-2288-12-34
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for synthesising survival data from clinical trials. An IPD meta-analysis can be achieved by either a two-stage or a one-stage approach, depending on whether the trials are analysed separately or simultaneously. A range of one-stage hierarchical Cox models have been previously proposed, but these are known to be computationally intensive and are not currently available in all standard statistical software. We describe an alternative approach using Poisson based Generalised Linear Models (GLMs). Methods: We illustrate, through application and simulation, the Poisson approach both classically and in a Bayesian framework, in two-stage and one-stage approaches. We outline the benefits of our one-stage approach through extension to modelling treatment-covariate interactions and non-proportional hazards. Ten trials of hypertension treatment, with all-cause death the outcome of interest, are used to apply and assess the approach. Results: We show that the Poisson approach obtains almost identical estimates to the Cox model, is additionally computationally efficient and directly estimates the baseline hazard. Some downward bias is observed in classical estimates of the heterogeneity in the treatment effect, with improved performance from the Bayesian approach. Conclusion: Our approach provides a highly flexible and computationally efficient framework, available in all standard statistical software, to the investigation of not only heterogeneity, but the presence of non-proportional hazards and treatment effect modifiers.
引用
收藏
页数:14
相关论文
共 48 条
[1]   Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey [J].
Ahmed, Ikhlaaq ;
Sutton, Alexander J. ;
Riley, Richard D. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[2]   Calculating the number needed to treat for trials where the outcome is time to an event [J].
Altman, DG ;
Andersen, PK .
BRITISH MEDICAL JOURNAL, 1999, 319 (7223) :1492-1495
[3]  
[Anonymous], 1999, STAT MED, V18, P1905
[4]  
[Anonymous], STAT SOFTW REL 11 0
[5]  
[Anonymous], 2000, Methods for meta-analysis in medical research
[6]   Meta-analysis of summary survival curve data [J].
Arends, Lidia R. ;
Hunink, M. G. Myriam ;
Stijnen, Theo .
STATISTICS IN MEDICINE, 2008, 27 (22) :4381-4396
[7]   Generating survival times to simulate Cox proportional hazards models [J].
Bender, R ;
Augustin, T ;
Blettner, M .
STATISTICS IN MEDICINE, 2005, 24 (11) :1713-1723
[8]   Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head [J].
Berlin, JA ;
Santanna, J ;
Schmid, CH ;
Szczech, LA ;
Feldman, HI .
STATISTICS IN MEDICINE, 2002, 21 (03) :371-387
[9]  
Carstensen B, 2004, WHO NEEDS COX MODEL
[10]  
Clayton D., 1993, STAT METHODS EPIDEMI